Mirus Bio introduces viral vector manufacturing reagents

By Will Morton, The Science Advisory Board contributing writer

August 13, 2021 -- Mirus Bio announced an expansion of its TransIT VirusGen platform that is compliant with good manufacturing practices (GMP) viral vector manufacturing to support cell and gene therapy development, process activities, and commercial production.

The company said it has been creating transfection reagents for years and can now offer those products to biopharmaceutical manufacturers at the GMP level. The expansion, named TransIT VirusGen GMP transfection reagent, is designed to enhance the delivery of packaging and transfer vector DNA to suspension and adherent HEK 293 cell types to increase production of recombinant adeno-associated virus and lentivirus vectors, the company said.

Mirus Bio
Mirus Bio's VirusGen GMP transfection kits for large-scale adeno-associated virus and lentivirus production. Image courtesy of Mirus Bio.

Virus titers can be further optimized with Mirus' other enhancers in the product line. According to the company, the full product line helps minimize safety and regulatory risks by using GMP raw materials in upstream manufacturing processes.

Forge Biologics to develop, manufacture GentiBio therapies
GentiBio and Forge Biologics have formed a strategic development and manufacturing partnership to advance GentiBio's immune tolerance platform.
Gyros, Cygnus introduce bioprocess impurity immunoassay solution
Gyros Protein Technologies has introduced its new HEK 293 host cell protein (HCP) immunoassay solution in collaboration with Cygnus Technologies. The...
Gamma to acquire majority stake in Mirus Bio
Gamma Biosciences has purchased a controlling stake in Mirus Bio, a developer of lipid-polymer nanocomplexes for nucleic acid delivery.
Aldevron adds AAV plasmid product offerings
Aldevron has launched rep/cap plasmids to support adeno-associated virus (AAV) vector manufacturing.
Glia-to-neuron conversion gene therapy can treat Huntington's disease
Using adeno-associated virus technology, researchers have developed a novel gene therapy that can regenerate functional neurons in mouse models of Huntington's...

Copyright © 2021 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter